Article
AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs
9 Feb 2016
Abstract excerpt
We previously reported that subretinal injection of AAV2/5 RK.cpde6β allowed long-term preservation of photoreceptor function and vision in the rod-cone dysplasia type 1 (rcd1) dog, a large animal model of naturally occurring PDE6β deficiency. The present study builds on these earlier findings to provide a detailed assessment of the long-term effects of gene therapy on the spatiotemporal pattern of retinal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
